Femme et Homme
- | Pays :
- Germany
- Belgium
- Switzerland
- ...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to assess safety and efficacy of two different doses of NV1FGF as compared to placebo. The secondary objective is to assess the pharmacokinetics of NV1FGF and FGF-1 protein.
Critère d'inclusion
- Peripheral arterial occlusive disease